Why is Shree Ganesh Bio falling/rising?

As of 17-Jul, Shree Ganesh Biotech India Ltd's stock price is currently at Rs 0.81, reflecting a decrease of Rs 0.01 or 1.22%. The stock has been underperforming, having fallen consecutively for the last two days with a total decline of 2.41%. It is trading below all key moving averages and is close to its 52-week low, just 1.23% away from Rs 0.80. The company has reported significant operating losses, with a negative EBITDA and a weak ability to service its debt, which is contributing to its poor performance. Additionally, the stock has seen a substantial drop in profitability, with a return on equity of only 2.60% and a year-over-year profit decline of 48%.
In the broader market context, Shree Ganesh Biotech's short-term performance has been notably worse than the benchmark Sensex, which has only declined by 1.12% over the past week while the stock has dropped by 4.71%. This stark contrast highlights the company's struggles relative to the overall market. Despite a rise in investor participation, as indicated by a 107.38% increase in delivery volume, the stock's fundamental weaknesses and negative financial results overshadow these positive signs, reinforcing the perception of it being a strong sell.